Recordati

Founded in 1926, Recordati, is a European pharmaceutical group with headquarters in Milan, Italy. It is dedicated to the research, development, manufacturing and marketing of pharmaceuticals in the main European countries. The company promotes a wide range of innovative pharmaceuticals, both proprietary and under license, in a number of therapeutic areas. Recordati’s current and growing coverage of the European pharmaceutical market makes it a partner of choice for new product licenses from companies which do not have European marketing organizations.

Moreover, the company is committed to the research of new drug entities in specific therapeutic areas like cardiovascular and urogenital. In fact its research team has proven scientific competence and a track record of discovery and development of original drugs.

Recordati has been listed on the Italian Stock Exchange since 1984.

Key consolidated data
• Consolidated revenue for 2006 is € 576.2 million.
• Operating income is € 120.3 million or 20.9% of revenue.
• Net income for 2006 is € 74.0 million.
• Net financial position at 31 December 2006 is positive by € 22.4 million.

Type:	NORMAL
Address:	Via Civitali, 1, 20148 Milan, Italy
Website:	www.recordati.it
Phone:	+39 02 487871
Fax:	+39 02 40073747